Based on our findings, 89Zr-CD133 IgG PET could be used for screening drugs for the capacity to suppress colon cancer stemness by noninvasively comparing tumor CD133 status before and after chemotherapy. The gene discussed is PROM1; the disease is colonic neoplasm.